Cargando…
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma
MYCN is a master regulator controlling many processes necessary for tumor cell survival. Here, we unravel a microRNA network that causes tumor suppressive effects in MYCN-amplified neuroblastoma cells. In profiling studies, histone deacetylase (HDAC) inhibitor treatment most strongly induced miR-183...
Autores principales: | Lodrini, Marco, Oehme, Ina, Schroeder, Christina, Milde, Till, Schier, Marie C., Kopp-Schneider, Annette, Schulte, Johannes H., Fischer, Matthias, De Preter, Katleen, Pattyn, Filip, Castoldi, Mirco, Muckenthaler, Martina U., Kulozik, Andreas E., Westermann, Frank, Witt, Olaf, Deubzer, Hedwig E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695529/ https://www.ncbi.nlm.nih.gov/pubmed/23625969 http://dx.doi.org/10.1093/nar/gkt346 |
Ejemplares similares
-
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
por: Fabian, Johannes, et al.
Publicado: (2016) -
Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2
por: Jayathilaka, Nimanthi, et al.
Publicado: (2012) -
HDAC3 functions as a positive regulator in Notch signal transduction
por: Ferrante, Francesca, et al.
Publicado: (2020) -
Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition
por: Lopez-Atalaya, Jose P., et al.
Publicado: (2013) -
Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription
por: Wang, Wen-Ling, et al.
Publicado: (2008)